What is Dorzolamide Hydrochloride?
Dorzolamide hydrochloride is a medication used to treat glaucoma and ocular hypertension. It functions as a carbonic anhydrase inhibitor, reducing the production of aqueous humor in the eye, which in turn lowers intraocular pressure [1].
How does Dorzolamide Hydrochloride work?
Dorzolamide hydrochloride works by inhibiting the enzyme carbonic anhydrase, which is present in the ciliary processes of the eye. This inhibition leads to a decrease in the secretion of bicarbonate ions, which subsequently reduces aqueous humor formation and lowers intraocular pressure [1].
What are the uses of Dorzolamide Hydrochloride?
Dorzolamide hydrochloride is prescribed for the treatment of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension [1]. It is often used as a single agent or in combination with other topical anti-glaucoma medications [1].
How is Dorzolamide Hydrochloride administered?
Dorzolamide hydrochloride is typically administered as eye drops. The usual dosage is one drop in the affected eye(s) three times daily [1].
What is the market for Dorzolamide Hydrochloride?
The market for dorzolamide hydrochloride is influenced by the prevalence of glaucoma and ocular hypertension, as well as the availability of generic alternatives. As of available data, dorzolamide hydrochloride is available as a generic medication, which generally leads to a competitive market landscape [2].
When does patent exclusivity expire for Dorzolamide Hydrochloride?
Information regarding specific patent expiry dates for dorzolamide hydrochloride is available through specialized patent databases. DrugPatentWatch.com provides a comprehensive resource for tracking drug patents and their expiration timelines. The market landscape for dorzolamide hydrochloride has evolved with patent expirations allowing for generic competition [3].
Who are the main manufacturers of Dorzolamide Hydrochloride?
With dorzolamide hydrochloride being available as a generic drug, multiple pharmaceutical companies manufacture and market it. These manufacturers are typically generic drug producers. Information on specific market players can be found by researching the drug's availability and regulatory approvals in different regions [2].
What are the risks and side effects associated with Dorzolamide Hydrochloride?
Common side effects of dorzolamide hydrochloride include stinging or burning of the eye, a bitter taste, headache, and blurred vision [1]. Less common but serious side effects can include allergic reactions and changes in blood counts [1]. Patients should consult their healthcare provider for a complete list of potential risks and side effects.
How does Dorzolamide Hydrochloride compare to other glaucoma treatments?
Dorzolamide hydrochloride belongs to the class of carbonic anhydrase inhibitors. Other classes of glaucoma medications include prostaglandin analogs, beta-blockers, alpha-adrenergic agonists, and miotics [4]. The choice of treatment depends on the individual patient's condition, response to medication, and tolerance of side effects. Combination therapy is also common, where dorzolamide hydrochloride may be used with drugs from different classes [4].
What is the pricing of Dorzolamide Hydrochloride?
As a generic medication, the price of dorzolamide hydrochloride is generally lower than its branded predecessors and varies depending on the manufacturer, pharmacy, and insurance coverage. Generic drug pricing is often competitive [2].
---
Sources:
[1] https://www.drugpatentwatch.com/
[2] https://www.drugpatentwatch.com/
[3] https://www.drugpatentwatch.com/
[4] https://www.drugpatentwatch.com/